LXRs Regulate ER Stress and Inflammation through Dynamic Modulation of Membrane Phospholipid Composition

被引:257
作者
Rong, Xin [1 ,2 ]
Albert, Carolyn J. [7 ,8 ]
Hong, Cynthia [1 ,2 ]
Duerr, Mark A. [7 ,8 ]
Chamberlain, Brian T. [3 ,4 ]
Tarling, Elizabeth J. [5 ]
Ito, Ayaka [1 ,2 ]
Gao, Jie [1 ,2 ]
Wang, Bo [1 ,2 ]
Edwards, Peter A. [5 ,6 ]
Jung, Michael E. [3 ,4 ]
Ford, David A. [7 ,8 ]
Tontonoz, Peter [1 ,2 ]
机构
[1] Univ Calif Los Angeles, Howard Hughes Med Inst, Los Angeles, CA 90095 USA
[2] Univ Calif Los Angeles, Dept Pathol & Lab Med, Los Angeles, CA 90095 USA
[3] Univ Calif Los Angeles, Calif NanoSyst Inst, Los Angeles, CA 90095 USA
[4] Univ Calif Los Angeles, Dept Chem & Biochem, Los Angeles, CA 90095 USA
[5] Univ Calif Los Angeles, Dept Med, Div Cardiol, Los Angeles, CA 90095 USA
[6] Univ Calif Los Angeles, Dept Biol Chem, Los Angeles, CA 90095 USA
[7] St Louis Univ, Dept Biochem & Mol Biol, St Louis, MO 63104 USA
[8] St Louis Univ, Cardiovasc Res Ctr, St Louis, MO 63104 USA
关键词
ENDOPLASMIC-RETICULUM STRESS; LYSOPHOSPHATIDYLCHOLINE ACYLTRANSFERASE 3; UNFOLDED PROTEIN RESPONSE; INSULIN-RESISTANCE; CHOLESTEROL; METABOLISM; OBESITY; RECEPTORS; MACROPHAGES; IDENTIFICATION;
D O I
10.1016/j.cmet.2013.10.002
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
The fatty acyl composition of phospholipids determines the biophysical character of membranes and impacts the function of membrane proteins. Here, we define a nuclear receptor pathway for the dynamic modulation of membrane composition in response to changes in cellular lipid metabolism. Ligand activation of liver X receptors (LXRs) preferentially drives the incorporation of polyunsaturated fatty acids into phospholipids through induction of the remodeling enzyme Lpcat3. Promotion of Lpcat3 activity ameliorates endoplasmic reticulum (ER) stress induced by saturated free fatty acids in vitro or by hepatic lipid accumulation in vivo. Conversely, Lpcat3 knockdown in liver exacerbates ER stress and inflammation. Mechanistically, Lpcat3 modulates inflammation both by regulating inflammatory kinase activation through changes in membrane composition and by affecting substrate availability for inflammatory mediator production. These results outline an endogenous mechanism for the preservation of membrane homeostasis during lipid stress and identify Lpcat3 as an important mediator of LXR effects on metabolism.
引用
收藏
页码:685 / 697
页数:13
相关论文
共 37 条
  • [1] Decrease in Membrane Phospholipid Unsaturation Induces Unfolded Protein Response
    Ariyama, Hiroyuki
    Kono, Nozomu
    Matsuda, Shinji
    Inoue, Takao
    Arai, Hiroyuki
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 2010, 285 (29) : 22027 - 22035
  • [2] BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911
  • [3] Disruption of endoplasmic reticulum structure and integrity in lipotoxic cell death
    Borradaile, Nica M.
    Han, Xianlin
    Harp, Jeffrey D.
    Gale, Sarah E.
    Ory, Daniel S.
    Schaffer, Jean E.
    [J]. JOURNAL OF LIPID RESEARCH, 2006, 47 (12) : 2726 - 2737
  • [4] A proteolytic pathway that controls the cholesterol content of membranes, cells, and blood
    Brown, MS
    Goldstein, JL
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1999, 96 (20) : 11041 - 11048
  • [5] Transcriptional integration of metabolism by the nuclear sterol-activated receptors LXR and FXR
    Calkin, Anna C.
    Tontonoz, Peter
    [J]. NATURE REVIEWS MOLECULAR CELL BIOLOGY, 2012, 13 (04) : 213 - 224
  • [6] Crosstalk between LXR and Toll-like receptor signaling mediates bacterial and viral antagonism of cholesterol metabolism
    Castrillo, A
    Joseph, SB
    Vaidya, SA
    Haberland, M
    Fogelman, AM
    Cheng, GH
    Tontonoz, P
    [J]. MOLECULAR CELL, 2003, 12 (04) : 805 - 816
  • [7] Stearoyl-coenzyme A desaturase 1 deficiency protects against hypertriglyceridemia and increases plasma high-density lipoprotein cholesterol induced by liver X receptor activation
    Chu, Kiki
    Miyazaki, Makoto
    Man, Weng Chi
    Ntambi, James M.
    [J]. MOLECULAR AND CELLULAR BIOLOGY, 2006, 26 (18) : 6786 - 6798
  • [8] Collins J.L., 2002, U.S. patent, Patent No. [2002/024632, 2002024632]
  • [9] Identification of a nonsteroidal liver X receptor agonist through parallel array synthesis of tertiary amines
    Collins, JL
    Fivush, AM
    Watson, MA
    Galardi, CM
    Lewis, MC
    Moore, LB
    Parks, DJ
    Wilson, JG
    Tippin, TK
    Binz, JG
    Plunket, KD
    Morgan, DG
    Beaudet, EJ
    Whitney, KD
    Kliewer, SA
    Willson, TM
    [J]. JOURNAL OF MEDICINAL CHEMISTRY, 2002, 45 (10) : 1963 - 1966